Read + Share
Hussain S, Klugarova J, Klugar M. Cost-effectiveness analyses of durvalumab consolidation therapy versus no
consolidation therapy after chemoradiotherapy in stage-III NSCLC. Lung Cancer 2022;170:11-19.
PMID: 35691134
|
 |
|
Hussain S, Klugarova J, Klugar M. Cost-effectiveness analyses of durvalumab consolidation therapy versus no
consolidation therapy after chemoradiotherapy in stage-III NSCLC. Lung Cancer 2022;170:11-19.
PMID: 35691134
|
|
|
|